ArticleRSC advances2025
Introduction and characterization of a novel Cu(ii)-based quaternary deep eutectic solvent and its application in the efficient synthesis of triazoles and tetrazoles under mild conditions as an inexpensive, reusable, benign, and dual solvent/catalyst medium.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploring Biofilm Inhibition Potential of Imidazo-Pyridine Linked Tetrazoles Against Candida albicans: Synthesis, Biological Evaluation With Computational Studies.Chemical biology & drug design · 2026Article
- Organic Named Reactions in Green Deep Eutectic Solvents (DESs).Topics in current chemistry (Cham) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep eutectic solvents consist of hydrogen bond donor and acceptor components. They are a new type of ionic liquids, and they have attracted the attention of many chemists in recent years. In this work, a quaternary deep eutectic solvent (QDES) was prepared using choline chloride, glycerol, l-arginine, and copper acetate. Its physicochemical properties were determined by Fourier transform infrared spectroscopy (FT-IR), thermal analysis (TGA), differential scanning calorimetry (DSC), hydrogen potential (pH), cyclic voltammetry (CV), viscosity, density, refractive index, ionic conductivity and spectrophotometer ultraviolet-visible (UV-Vis). Further, as a novel benign solvent/catalyst for the synthesis of 1,4-disubstituted-1,2,3-triazole, 4-substituted-1
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.